1
18
S.F. Sucena et al. / Spectrochimica Acta Part A 89 (2012) 114–118
complex, being comparable to the inhibitory effect of the standard
antibiotics ofloxacin and imipenem used as positive controls, and
less active than the standard antibiotic chloramphenicol in the MIC
assays for P. aeruginosa ATCC 27853, P. aeruginosa 31NM and E. coli
ATCC 25922. The observed results are also comparable to a novel
gold(I)–mercaptothiazoline complex, [AuCN(C H5NS )], recently
published in the literature [15]. Rimantadine hydrochloride did not
exhibit antibacterial activity under the same experimental condi-
tions. Antibiotic sensitivity profiles of bacterial strains are listed in
Table 2.
References
[1] R. Rosenberg, L. Van Camp, T. Krigas, Nature 205 (1965) 698–699.
[2] R. Bakhtiar, E.I. Ochiai, Gen. Pharmacol. 32 (1999) 525–540.
[3] M.A. Jakupec, M. Galanski, V.B. Arion, C.G. Hartinger, B.K. Keppler, Dalton Trans.
(2008) 183–194.
[
[
[
4] G.G. de Gracia, Burns 27 (2001) 67–74.
5] H.J. Klasen, Burns 26 (2000) 131–138.
6] K. Nomiya, H. Yokoyama, Dalton Trans. 12 (2002) 2483–2490.
3
2
[7] R.B. Thurman, C.P. Gerba, Crit. Rev. Environ. Control 18 (1988) 295–315.
[
[
8] N. Farrell, Coord. Chem. Rev. 232 (2002) 1–4.
9] P.J. Sadler, R.E. Sue, The chemistry of gold drugs, Metal-Based Drugs (1994)
107–144.
[
[
10] L.L. Marques, G.M. Oliveira, E.S. Lang, M.M.A. Campos, L.R.S. Gris, Inorg. Chem.
Commun. 10 (2007) 1083–1087.
11] A.J. Canumalla, N. Al-Zamil, M. Phillips, A.A. Isab, C.F. Shaw III, J. Inorg. Biochem.
4
. Conclusions
8
5 (2001) 67–76.
A new gold(I) complex with rimantadine of molar composition
:1 metal/ligand was obtained and characterized. The 1H, C and
N NMR data, in addition to the IR spectroscopic measurements,
[12] A.T.M. Fiori, W.R. Lustri, A. Magalhães, P.P. Corbi, Inorg. Chem. Commun. 14
(2011) 738–740.
[13] R. Noguchi, A. Hara, A. Sugie, K. Nomiya, Inorg. Chem. Commun. 9 (2006)
13
1
1
5
355–359.
support coordination of rimantadine to Au(I) through the nitrogen
atom of NH2 group and also through the carbon atom of cyanide.
Initial kinetic studies have demonstrated the stability of the com-
pound in solution. Thermal decomposition of the complex starts at
[
[
[
[
14] S. Ray, R. Mohan, J.K. Singh, M.K. Samantaray, M.M. Shaikh, D. Panda, P. Ghosh,
J. Am. Chem. Soc. 129 (2007) 15042–15053.
15] C. Abbehausen, J.F. Castro, M.B.M. Spera, T.A. Heinrich, C.M. Costa-Neto, W.R.
Lustri, A.L.B. Formiga, P.P. Corbi, Polyhedron 30 (2011) 2354–2359.
16] Y. Luzinova, G.T. Dobbs, R. Sassen, B. Mizaikoff, Org. Geochem. 40 (2009)
1143–1150.
◦
◦
1
55 C, leading to the formation of Au as the final residue of the
17] S.D. Cady, J. Wang, Y. Wu, W.F. Grado, M. Hong, J. Am. Chem. Soc. 133 (2011)
thermal treatment. DFT studies confirmed coordination of RTD to
Au(I) through the nitrogen atom of the NH2 group as a minimum
of the potential energy surface with calculations of the Hessians,
showing no imaginary frequencies.
4274–4284.
[18] M.W. Schmidt, K.K. Baldridge, J.A. Boatz, S.T. Elbert, M.S. Gordon, J.H. Jensen,
S.K.N. Matsunaga, K.A. Nguyen, S. Su, T.L. Windus, M. Dupuis, J.A. Montgomery
Jr., J. Comput. Chem. 14 (1993) 1347–1363.
[
19] P.J. Hay, W.R. Wadt, J. Chem. Phys. 82 (1985) 270–283.
Based on the chemical, spectroscopic and DFT studies the fol-
lowing structure for the Au–RTD complex is proposed in Fig. 4.
Biological studies revealed the effective antibacterial activity in
vitro of the complex against Gram-negative and -positive bacterial
strains. Further studies are envisaged in order to evaluate the in
vivo antibacterial activities of the Au–RTD complex and its possible
application in the treatment of skin infections.
[
20] P.C. Hariharan, J.A. Pople, Theor. Chim. Acta 28 (1973) 213–222.
[21] R. Ditchfie, W.J. Hehre, J.A. Pople, J. Chem. Phys. 54 (1971) 720–723.
[
[
22] W.J. Hehre, R. Ditchfield, J.A. Pople, J. Chem. Phys. 56 (1972) 2257–2261.
23] M.M. Francl, W.J. Pietro, W.J. Hehre, J.S. Binkley, M.S. Gordon, D.J. DeFrees, J.A.
Pople, J. Chem. Phys. 77 (1982) 3654–3665.
[24] C. Lee, W. Yang, R.G. Parr, Phys. Rev. B 37 (1988) 785–789.
[25] A.W. Bauer, W.M.M. Kirby, J.C. Sheris, M. Turck, Am. J. Clin. Pathol. 45 (1966)
493–496.
[
26] Clinical and Laboratory Standards Institute (CLSI), Performance Standards for
Antimicrobial Susceptibility Testing, Seventeenth Informational Supplement,
Wayne, PA, USA, 2007.
Acknowledgments
[
27] K. Nakamoto, Infrared and Raman Spectra of Inorganic and Coordination Com-
pounds, Part B, Fifth ed., John Wiley & Sons, New York, 1997.
This study was supported by grants from FAPESP (2006/55367-
[
28] R.M. Silverstein, F.X. Webster, D.J. Kiemle, Spectrometric Identification
2
, 2008/56777-5) and CNPq (575313/2008-0 and 472768/2010-3).
of Organic Compounds, Seventh ed., John Wiley
005.
29] P.P. Corbi, A.C. Massabni, Spectrochim. Acta A 64 (2006) 418–419.
30] P.P. Corbi, F. Cagnin, L.P.B. Sabeh, A.C. Massabni, C.M. Costa-Neto, Spectrochim.
Acta A 66 (2007) 1171–1174.
& Sons, New York,
2
Authors are also grateful to Professor Carol H. Collins for English
revision of the manuscript.
[
[
[
[
31] K.J. Kristopher, R.E. Wasylishen, Inorg. Chem. 48 (2009) 2316–2332.
32] J.A. Bonacin, A.L.B. Formiga, V.H.S. de Melo, H.E. Toma, Vib. Spectrosc. 44 (2007)
Appendix A. Supplementary data
133–141.
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.saa.2011.12.043.
[33] Powder Diffraction Database – CD ROM, File 04-0784, The International Centre
for Diffraction Data (JCPDS-ICDD) (1997).